Cargando…

In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma

Rationale: Intrinsic brain tumors, such as gliomas are largely resistant to immunotherapies including immune checkpoint blockade. Adoptive cell therapies (ACT) including chimeric antigen receptor (CAR) or T cell receptor (TCR)-transgenic T cell therapy targeting glioma-associated antigens are an eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunger, Jessica, Schregel, Katharina, Boztepe, Berin, Agardy, Dennis Alexander, Turco, Verena, Karimian-Jazi, Kianush, Weidenfeld, Ina, Streibel, Yannik, Fischer, Manuel, Sturm, Volker, Santarella-Mellwig, Rachel, Kilian, Michael, Jähne, Kristine, Sahm, Katharina, Wick, Wolfgang, Bunse, Lukas, Heiland, Sabine, Bunse, Theresa, Bendszus, Martin, Platten, Michael, Breckwoldt, Michael O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614679/ https://www.ncbi.nlm.nih.gov/pubmed/37908732 http://dx.doi.org/10.7150/thno.87248

Ejemplares similares

T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
por: Turco, Verena, et al.
Publicado: (2023)

Diagnostic value of gadolinium contrast administration for spinal cord magnetic resonance imaging in multiple sclerosis patients and correlative markers of lesion enhancement
por: Karimian-Jazi, Kianush, et al.
Publicado: (2021)

Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopy
por: Hahn, Artur, et al.
Publicado: (2020)

Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI
por: Karimian-Jazi, Kianush, et al.
Publicado: (2018)

Genetically Modified Cellular Therapies for Malignant Gliomas
por: Kilian, Michael, et al.
Publicado: (2021)

Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes
por: Blobner, Jens, et al.
Publicado: (2021)

Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM)
por: Karimian-Jazi, Kianush, et al.
Publicado: (2020)

K27M-mutant histone-3 as a novel target for glioma immunotherapy
por: Ochs, Katharina, et al.
Publicado: (2017)

A H3K27M-targeted vaccine in adults with diffuse midline glioma
por: Grassl, Niklas, et al.
Publicado: (2023)

An AI-based segmentation and analysis pipeline for high-field MR monitoring of cerebral organoids
por: Deininger, Luca, et al.
Publicado: (2023)

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
por: Berghoff, Anna Sophie, et al.
Publicado: (2020)

Emerging targets for anticancer vaccination: IDH
por: Platten, M., et al.
Publicado: (2021)

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
por: Grassl, Niklas, et al.
Publicado: (2023)

AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas
por: Bunse, Lukas, et al.
Publicado: (2022)

T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
por: Kilian, Michael, et al.
Publicado: (2022)

A vaccine targeting mutant IDH1 in newly diagnosed glioma
por: Platten, Michael, et al.
Publicado: (2021)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020)

Clinical and Translational Advances in Glioma Immunotherapy
por: Bunse, Lukas, et al.
Publicado: (2022)

Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020)

T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells
por: Lu, Kevin Hai-Ning, et al.
Publicado: (2022)

Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease
por: Breckwoldt, Michael O., et al.
Publicado: (2019)

Site-Specific Considerations on Engineered T Cells for Malignant Gliomas
por: Elmadany, Nirmeen, et al.
Publicado: (2022)

Voluntary peer-led exam preparation course for international first year students: Tutees’ perceptions
por: Huhn, Daniel, et al.
Publicado: (2015)

Correlated magnetic resonance imaging and ultramicroscopy (MR-UM) is a tool kit to assess the dynamics of glioma angiogenesis
por: Breckwoldt, Michael O, et al.
Publicado: (2016)

Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma
por: Seidel, Clemens, et al.
Publicado: (2011)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
por: Friedrich, Mirco, et al.
Publicado: (2022)

IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
por: Kickingereder, Philipp, et al.
Publicado: (2015)

Monosynaptic trans-collicular pathways link mouse whisker circuits to integrate somatosensory and motor cortical signals
por: Martín-Cortecero, Jesús, et al.
Publicado: (2023)

Transmembrane protein TMEM170A is a newly discovered regulator of ER and nuclear envelope morphogenesis in human cells
por: Christodoulou, Andri, et al.
Publicado: (2016)

Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2015)

Clinical Value of Susceptibility Weighted Imaging of Brain Metastases
por: Schwarz, Daniel, et al.
Publicado: (2020)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
por: Anssar, Tareq M., et al.
Publicado: (2019)

ISWI is a RanGTP-dependent MAP required for chromosome segregation
por: Yokoyama, Hideki, et al.
Publicado: (2009)

Characterization of experimental diabetic neuropathy using multicontrast magnetic resonance neurography at ultra high field strength
por: Schwarz, Daniel, et al.
Publicado: (2020)

Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma
por: Zhang, Xin-Wen, et al.
Publicado: (2021)

Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells
por: Kovalchuk, Bogdana, et al.
Publicado: (2020)

Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
por: Ott, Martina, et al.
Publicado: (2012)

Three-Dimensional Reconstruction of Bacteria with a Complex Endomembrane System
por: Santarella-Mellwig, Rachel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_58fck5drnul3uan8020birlqkf